Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid Tumors.
Journal: Clinical pharmacology in drug development
Published: October 06, 2020
Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3.
Journal: Clinical therapeutics
Published: December 11, 2017
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function.
Journal: Clinical pharmacology : advances and applications
Published: November 30, 2017
Erratum for Kersemaekers et al., Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects.
Journal: Antimicrobial agents and chemotherapy
Published: June 22, 2016
A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
Journal: Cancer chemotherapy and pharmacology
Published: October 21, 2015
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.
Journal: Journal of clinical pharmacology
Published: March 29, 2015
A fit for purpose training programme for the decontamination of personnel.
Journal: Journal of radiological protection : official journal of the Society for Radiological Protection
Published: March 14, 2015
Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects.
Journal: Antimicrobial agents and chemotherapy
Published: December 17, 2014
Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy.
Journal: European journal of clinical pharmacology
Published: July 10, 2014
Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatin.
Journal: Antimicrobial agents and chemotherapy
Published: March 27, 2013
Pharmacokinetic interactions between the hepatitis C virus protease inhibitor boceprevir and ritonavir-boosted HIV-1 protease inhibitors atazanavir, darunavir, and lopinavir.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 17, 2012
A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers.
Journal: The Journal of antimicrobial chemotherapy
Published: July 27, 2012
Last Updated: 09/26/2026